Mathieu Chevrier

Stock Analyst at Citigroup

(0.49)
# 3,851
Out of 4,793 analysts
2
Total ratings
n/a
Success rate
-1.95%
Average return
Main Sectors:

Stocks Rated by Mathieu Chevrier

ResMed
Mar 5, 2025
Upgrades: Buy
Price Target: n/a
Current: $205.17
Upside: -